Efanesoctocog alfa API Manufacturers

compare suppliers & get competitive offers

Pharmaoffer_donkere_achtergrond
No suppliers found
Sorry, there are currently no suppliers listed for this ingredient. Hopefully we can help you with other ingredients.
Notify me!
Want to be the first to find out when a supplier for Efanesoctocog alfa is listed?

Join our notification list by following this page.

List your company
Are you a supplier of Efanesoctocog alfa or other APIs and are you looking to list your company on Pharmaoffer?

Click the button below to find out more

Find CDMO
Looking for a CDMO/CMO that can help you with your pharmaceutical needs?

Click the button below to switch over to the contract services area of Pharmaoffer.

Looking for Efanesoctocog alfa API 2252477-42-0?

Description:
Here you will find a list of producers, manufacturers and distributors of Efanesoctocog alfa. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Efanesoctocog alfa 
Synonyms:
Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl  
Cas Number:
2252477-42-0 
DrugBank number:
DB16662 
Unique Ingredient Identifier:
WH7BHQ0RB4

General Description:

Efanesoctocog alfa, identified by CAS number None, is a notable compound with significant therapeutic applications. Efanesoctocog alfa is under investigation in clinical trial NCT04759131 (Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A).

Classification:

Efanesoctocog alfa belongs to the None, classified under the direct parent group Peptides. This compound is a part of the Organic Compounds, falling under the Organic Acids superclass, and categorized within the Carboxylic Acids and Derivatives class, specifically within the Amino Acids, Peptides, and Analogues subclass.

Categories:

Efanesoctocog alfa is categorized under the following therapeutic classes: Amino Acids, Peptides, and Proteins, Proteins, Recombinant Proteins. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.